Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

@article{Gandra2006TotalAC,
  title={Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.},
  author={Shravanthi R. Gandra and Lesa W Lawrence and Bhash M Parasuraman and Robert M. Darin and Justin J. Sherman and Jerry L Wall},
  journal={Journal of managed care pharmacy : JMCP},
  year={2006},
  volume={12 7},
  pages={546-54}
}
BACKGROUND Type 2 diabetes (T2DM) is one of the most prevalent and costly chronic conditions in the United States. Macrovascular disease (MVD) remains a common and costly comorbidity in T2DM. Understanding the impact of MVD on total health care costs in patients with T2DM is of great importance to managed care organizations (MCOs). OBJECTIVE To examine from the perspective of an MCO the impact of MVD on health care costs in patients with T2DM and in a matched comparison group of patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis

Diabetes therapy : research, treatment and education of diabetes and related disorders • 2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 31 references

The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes

JA O'Brien, AR Patrick, J Caro
Diabetes Care • 2002

Similar Papers

Loading similar papers…